Member Info for jimmy2011

what i find interesting is the web site change on sgsc,( data sharing) what a coincidence? excalibure are pulling all the strings here.
sgsc have covered themselves regarding reasults are in and not being with held to the choosen few,( investers)
gla

This is my take on it. The above text from the Vela accounts state the directors will be remunerated, but doesn’t detail how, because no remuneration scheme was set in place at the time of publishing. We know 1graine appointed Chris Evans, Martin Walton, Steve Wingield (ceo and vela directors) and I believe this is the engine for remuneration as 1graine is set to benefit from a successful trial. The writing is on the wall/read between the lines etc

LONDON – August 17: Excalibur Medicines Limited, a subsidiary of Excalibur Healthcare Services Ltd., announced today that the clinical team will report on the ARCADIA trial on September 6, 2021.
Excalibur Medicines Ltd (“EML”) has secured exclusive rights to and owns the patents on a drug, AZD1656, which is being developed as a potential therapeutic for people with diabetes suffering from COVID-19. The ARCADIA trial which took place across 31 sites was completed in July this year.

rainbow chasing is a dangerous game , take copl for instance, open nearly 50% up, a lot of buys are stuck in now as sp is down 40% from this morning,
gla

of the vela board news must be close,
do you think the sp may be held back for contibution of shares to new board member?
gla

i think there has been a little update on sgsc website, the data sharing link, ive not seen that before,?
but not relivent to our trial,
gla

and of coarse sgsc web site,
not rns.

it could happen, news will come via twitter first by sgsc, and twitter is open 24/7.

pump and dump is part and parcel of any stock approaching news, it can also work in our favour,it generates interest in volume, and 1/5 of investers will get caught in the pump , so its expected at some time,
gla

it would no surprise me if, the deal with sgsc / evans was no orcasted be for jn joined vela,
and vela, (because of mc/sp) was the lucky one that jn approched,
because otherwise it does not add up for such a mino to get the oppertuneity to employ such a high / succsesful director as jn,
gla

(pasted from telegram board )

are you ready for this? a bit deep.
not to long ago, a question was asked, why no movement so close to trial?
1 of the answers was, vela is a mino in a big market,
that answer is so true,(just because we come across vela, does not mean the other 85% of market has)
i like alot of others did not invest in vela,
we invested in james nomand,(the new striker)
so this little mino that the new striker has joined,
picked up a few smallish investments, throws him self in and spends 1/3 of the market cap, 2mill, in one hit,whyyy

because, jn knows, more return from a mino to a whale, than a killer whale to a blue whale,(size)
most of our small investments are taking shape,(long term return)
but arcadia could be,(no) will be the start of a very succesful desision of jn's to join mino vela in the first place.
vela one day will be huge.
gla

i see its mostly you and i that seem to ( hopefully think) that indications of trials being succesfull are being shown via backdoor movements .
hopr we are right.lol
gla news soon.

i see acker has increased his holding from 3% to 9% in oscillate plc, who also have investment in arcadia .
gla

they have taken positions in igrain and discovore, tr1's , who are invested in arcadia trials, not vela,

thanks for your answer big dave, as i say, the evans team really have got a lot of confidence in this trial and i my opinion, have put there money/reputaion where there mouth is , sort to speak.
2/4 weeks and all will become clear.
as a invester, i have a lot of confidence in sgsc ,sir prof evans and his team also jn with our 2million quid , mubadala and ukri investergating teams have not dived in with out scrupinizing the possible out come of this trial.
gla

p/s
not to mention why acker and edwards have sneaked in the back door with substantal investments,
2 very high profile investers who , on reputation do not back donkeys.

as i read the sgsc write up regarding the arcadia trial it states,
az agreed to provide the drug substance for the trial.

so , what i dont understand is, if prof evans owns the patant of azd 1656 why we had to have az's permission or provide drug substance ?
so that brings me to the question, when did evans aquire the patant and at what cost/conditions ?

next question,
why has the excalibur team,( who have personal investment in trial ) created igraine ,who also have personal investment,
along with 1 of the directors, who also have , (ore) discoverore plc, and yet again have investment in arcadia trials, via angelfish (igraine) ,
evans and the excalibur team have seemed to put a lot of work/money into this trial, also the big investers evans/sgsc have gone to with cap in hand,
the more i read between the lines, the more i convince myself this has the potential of being one of a life time investment,
on that note,
gla

with this piece of the jigsaw in place, i am in the thoughts that news will be released soon, may-be this week or mid next.
evans in my opinion pulls a lot of strings within this investment/trial and will know be incontact with sgsc, pushing them along.
gla

giving lth a bit of confidence,
gl

sorry postie, but we have 200k in mti,
gla